Liquidia Technologies, Inc. (NASDAQ:LQDA) CAO Sells $20,771.02 in Stock

Key Points

• Dana Boyle, the Chief Accounting Officer of Liquidia Technologies, sold 1,063 shares of stock on July 28th for a total of $20,771.02, representing a 0.57% decrease in his ownership.
• Liquidia Technologies' stock is currently trading at $19.11, having decreased by 0.8%, with a market capitalization of $1.63 billion.
• Institutional investors now hold 64.54% of Liquidia Technologies' stock, indicating significant interest from larger financial entities.

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) CAO Dana Boyle sold 1,063 shares of the stock in a transaction that occurred on Monday, July 28th. The shares were sold at an average price of $19.54, for a total value of $20,771.02. Following the completion of the sale, the chief accounting officer directly owned 186,105 shares of the company's stock, valued at $3,636,491.70. The trade was a 0.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Dana Boyle also recently made the following trade(s):

• On Monday, July 14th, Dana Boyle sold 1,193 shares of Liquidia Technologies stock. The shares were sold at an average price of $14.28, for a total value of $17,036.04.

Liquidia Technologies Price Performance

NASDAQ:LQDA traded down $1.01 during trading hours on Friday, hitting $17.68. The company's stock had a trading volume of 3,308,216 shares, compared to its average volume of 1,630,963. The business's 50-day moving average is $15.00 and its two-hundred day moving average is $14.83. The company has a market capitalization of $1.51 billion, a PE ratio of -11.19 and a beta of -0.01. The company has a debt-to-equity ratio of 2.08, a quick ratio of 2.91 and a current ratio of 2.93. Liquidia Technologies, Inc. has a 52-week low of $8.26 and a 52-week high of $20.33.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.42) by ($0.03). The business had revenue of $3.12 million during the quarter, compared to analysts' expectations of $3.23 million. Liquidia Technologies had a negative return on equity of 177.91% and a negative net margin of 903.80%. As a group, research analysts anticipate that Liquidia Technologies, Inc. will post -1.51 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Hurley Capital LLC purchased a new position in Liquidia Technologies in the first quarter worth $32,000. GAMMA Investing LLC increased its position in shares of Liquidia Technologies by 65.6% in the first quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock valued at $44,000 after buying an additional 1,173 shares in the last quarter. Quarry LP purchased a new position in shares of Liquidia Technologies in the first quarter valued at $79,000. Summit Investment Advisors Inc. increased its position in shares of Liquidia Technologies by 35.0% in the fourth quarter. Summit Investment Advisors Inc. now owns 6,632 shares of the company's stock valued at $78,000 after buying an additional 1,719 shares in the last quarter. Finally, Corsair Capital Management L.P. purchased a new position in shares of Liquidia Technologies in the first quarter valued at $148,000. Hedge funds and other institutional investors own 64.54% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Bank of America decreased their price objective on Liquidia Technologies from $25.00 to $23.00 and set a "buy" rating for the company in a report on Wednesday, June 11th. Scotiabank increased their price target on Liquidia Technologies from $36.00 to $37.00 and gave the stock a "sector outperform" rating in a report on Wednesday, May 28th. Needham & Company LLC reaffirmed a "buy" rating on shares of Liquidia Technologies in a report on Monday, June 2nd. HC Wainwright increased their price target on Liquidia Technologies from $29.00 to $35.00 and gave the stock a "buy" rating in a report on Wednesday, May 28th. Finally, Wall Street Zen raised Liquidia Technologies from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. One analyst has rated the stock with a sell rating, one has issued a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $26.89.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).